Building a haemophilia-specific navigator in Epic® Electronic Health Records: Single-centre preliminary experience.


Journal

Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916

Informations de publication

Date de publication:
Sep 2023
Historique:
revised: 25 07 2023
received: 30 05 2023
accepted: 10 08 2023
medline: 19 9 2023
pubmed: 30 8 2023
entrez: 30 8 2023
Statut: ppublish

Résumé

With the increasing complexity of haemophilia care and the advent of numerous therapeutic innovations, there is an unmet need for documentation and data collection tools tailored to people with haemophilia (PwH). To date, no fully integrated haemophilia-specific electronic health record (EHR) has been described in the literature. To evaluate the feasibility of integrating a haemophilia-specific navigator into the Epic EHR. Based on clinical experience and registry datasets, we identified key variables describing both PwH and carriers of haemophilia. These were then incorporated into a REDCap database, which served as a starting point for the development of a comprehensive haemophilia flowsheet. We built a dedicated haemophilia navigator within Epic that includes a flowsheet featuring up to 212 variables, as well as customised note templates and patient lists integrating data from the haemophilia flowsheet. It was feasible to develop a haemophilia navigator within Epic over the course of 12 months. The navigator's flowsheet enables systematic and comprehensive clinical assessment of PwH and carriers, while customised patient lists provide a quick summary of each patient's profile to the haemophilia treatment centre staff and highlight issues that require an intervention. In our clinical practice, patients actively participated in the new documentation process and responded positively to the navigator. Adapting EHRs to the needs of PwH and carriers promotes holistic care for this population and provides an opportunity for patient empowerment. Such haemophilia-specific EHRs are expected to promote standardisation of care and facilitate the collection of registry data on a national and international level.

Identifiants

pubmed: 37647202
doi: 10.1111/hae.14846
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1219-1225

Subventions

Organisme : Swedish Orphan Biovitrum (SOBI), Belgium
Organisme : CSL Behring, Belgium

Informations de copyright

© 2023 John Wiley & Sons Ltd.

Références

Cuker A. Treatment of hemophilia: on the precipice of a revolution. Hematologist. 2017;14(1). doi:10.1182/hem.V14.1.6993
De Moerloose P, Fischer K, Lambert T, et al. Recommendations for assessment, monitoring and follow-up of patients with haemophilia. Haemophilia. 2012;18(3):319-325. doi:10.1111/j.1365-2516.2011.02671.x
Beny K, du Sartz de Vigneulles B, Carrouel F, et al. Haemophilia in France: modelisation of the clinical pathway for patients. Int J Environ Res Public Health. 2022;19(2):646. doi:10.3390/ijerph19020646
folio3 Digital Health. Which Hospitals Use EPIC software in different states? Complete Guide 2023. Accessed April 11, 2023. https://digitalhealth.folio3.com/blog/which-hospitals-use-epic/#What_countries_use_Epic
Bienvenue! Celebrating One Year Since Go-Live at Brussels Hospital, First in Belgium to Use Epic. Published November 2, 2021. Accessed February 1, 2023. https://www.epic.com/epic/post/bienvenue-celebrating-one-year-since-go-live-at-brussels-hospital-first-in-belgium-to-use-epic
EMR Systems-A Complete Catalog of EMR/EHR Software Systems. Epic EMR Software. Accessed March 3, 2023. https://www.emrsystems.net/epic-ehr-software/
Bansler JP. Challenges in user-driven optimization of EHR: a case study of a large Epic implementation in Denmark. Int J Med Inform. 2021;148:104394. doi:10.1016/j.ijmedinf.2021.104394
Krushelnytskyy MD, Youngblood MW, Lesniak MS, et al. Optimizing the patient handoff and progress note documentation efficiency in the EPIC EMR system within a neurosurgery residency: a quality improvement initiative. J Clin Neurosci. 2022;105:86-90. doi:10.1016/j.jocn.2022.09.007
Unni S, Yao Y, Milne N, Gunning K, Curtis JR, LaFleur J. An evaluation of clinical risk factors for estimating fracture risk in postmenopausal osteoporosis using an electronic medical record database. Osteoporos Int. 2015;26(2):581-587. doi:10.1007/s00198-014-2899-7
Volk R, Obeid N. What can we do about Dr. Google? Using the electronic medical record (EMR) to prescribe reliable online patient education. J Med Lib Assoc. 2019;107(4). doi:10.5195/jmla.2019.774
Rogers CK, Parulekar M, Malik F, Torres CA. A local perspective into electronic health record design, integration, and implementation of screening and referral for social determinants of health. Perspect Health Inf Manag. 2022;19(Spring):1g.
Dinh-Le C, Chuang R, Chokshi S, Mann D. Wearable health technology and electronic health record integration: scoping review and future directions. JMIR Mhealth Uhealth. 2019;7(9):e12861. doi:10.2196/12861
Wagner K, Pingle SR, Walker K, Floridia E, Medina C, Rowe CK. Harnessing the epic electronic medical record to track indwelling ureteral stents in a pediatric population. J Pediatr Urol. 2022;18(1):23.e1-23.e5. doi:10.1016/j.jpurol.2021.10.007
Reagor JA. A dedicated perfusion electronic medical record with discrete epic integration. J Extra Corpor Technol. 2017;49(4):291-298.
Biering-Sørensen F, Cohen S, Rodriguez GM, Tausk K, Martin J. Electronic medical record: data collection and reporting for spinal cord injury. Spinal Cord Ser Cases. 2018;4(1):70. doi:10.1038/s41394-018-0106-3
Kolb EA, Coyne E, Crowgey E, et al. Improving care of patients with sickle cell disease through discrete clinical data extraction and automated analysis of the electronic healthcare records. Blood. 2016;128(22):2331-2331. doi:10.1182/blood.V128.22.2331.2331
Gandrup J, Li J, Izadi Z, et al. Three quality improvement initiatives and performance of rheumatoid arthritis disease activity measures in electronic health records: results from an Interrupted Time Series Study. Arthritis Care Res (Hoboken). 2020;72(2):283-291. doi:10.1002/acr.23848
Park JS, Wong J, Cohen H. Hepatitis C virus screening of high-risk patients in a community hospital emergency department: retrospective review of patient characteristics and future implications. PLoS One. 2021;16(6):e0252976. doi:10.1371/journal.pone.0252976
World Federation of Hemophilia. World Bleeding Disorders Registry-Hemophilia and VWD Data Set. Published February 2023. Accessed March 9, 2023. https://wfh.org/wp-content/uploads/2023/02/WBDR-complete-dataset-EN.pdf
Fischer K, Ljung R, Platokouki H, et al. Prospective observational cohort studies for studying rare diseases: the European PedNet Haemophilia Registry. Haemophilia. 2014;20(4):e280-e286. doi:10.1111/hae.12448
Krumb E, Hermans C, Are There Differences Between Carriers of Haemophilia A and B? ClinicalTrials.gov. Accessed March 15, 2023. https://clinicaltrials.gov/ct2/show/study/NCT05217992
Brands MR, Gouw SC, Beestrum M, Cronin RM, Fijnvandraat K, Badawy SM. Patient-centered digital health records and their effects on health outcomes: systematic review. J Med Internet Res. 2022;24(12):e43086. doi:10.2196/43086
Srivastava A, Santagostino E, Dougall A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(S6):1-158. doi:10.1111/hae.14046
Lekstrom-Himes J, Augustine EF, Brower A, et al. Data sharing to advance gene-targeted therapies in rare diseases. Am J Med Genet C Semin Med Genet. 2023;193(1):87-98. doi:10.1002/ajmg.c.32028
Makris M, Calizzani G, Fischer K, et al. EUHASS: the European Haemophilia Safety Surveillance system. Thromb Res. 2011;127:S22-S25. doi:10.1016/S0049-3848(10)70150-X
American Thrombosis and Hemostasis Network (ATHN). Advancing research with better data through the ATHNdataset. Accessed April 26, 2023. https://athn.org/what-we-do/national-projects/athndataset.html
Martinoli C, Della AO, Di Minno G, et al. Development and definition of a simplified scanning procedure and scoring method for Haemophilia Early Arthropathy Detection with Ultrasound (HEAD-US). Thromb Haemost. 2013;109(06):1170-1179. doi:10.1160/TH12-11-0874
Hilliard P, Funk S, Zourikian N, et al. Hemophilia joint health score reliability study. Haemophilia. 2006;12(5):518-525. doi:10.1111/j.1365-2516.2006.01312.x
Timmer MA, Gouw SC, Feldman BM, et al. Measuring activities and participation in persons with haemophilia: a systematic review of commonly used instruments. Haemophilia. 2018;24(2):e33-e49. doi:10.1111/hae.13367
Lobet S, Lambert C, Foubert A, et al. ACTIVLIM-Hemo: a new self-reported, unidimensional and linear measure of activity limitations in persons with haemophilia. Haemophilia. 2023;29(1):317-328. doi:10.1111/hae.14705
Hertzum M, Ellingsen G, Cajander Å. Implementing large-scale electronic health records: experiences from implementations of Epic in Denmark and Finland. Int J Med Inform. 2022;167:104868. doi:10.1016/j.ijmedinf.2022.104868

Auteurs

Evelien Krumb (E)

Haemostasis and Thrombosis Unit, Division of Adult Haematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Nicolas Vanlangendonck (N)

Haemostasis and Thrombosis Unit, Division of Adult Haematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Catherine Lambert (C)

Haemostasis and Thrombosis Unit, Division of Adult Haematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Sébastien Lobet (S)

Haemostasis and Thrombosis Unit, Division of Adult Haematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Secteur de kinésithérapie, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.
Neuromusculoskeletal Lab (NMSK), Secteur des Sciences de la Santé, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

An Van Damme (A)

Department of Paediatric Haematology and Oncology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Cédric Hermans (C)

Haemostasis and Thrombosis Unit, Division of Adult Haematology, Cliniques universitaires Saint-Luc, Université catholique de Louvain (UCLouvain), Brussels, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH